ArticleCancer research communications2022

TAK-676: A Novel Stimulator of Interferon Genes (STING) Agonist Promoting Durable IFN-dependent Antitumor Immunity in Preclinical Studies.

Elizabeth Carideo Cunniff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.